Supply of testing for SARS-CoV-2 antibody and PCR testing

Concepts

• bristol
• blood analysis
• nhs blood and transplant
• nhsbt
• sars
• supply of testing
• sars-cov-2 antibody
• pcr testing
• high level of antibody
• sufficient level of antibody

Location

Filton

Description

NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to explore the efficacy of donated plasma in the treatment of severe COVID-19 disease. Plasma will be donated by individuals who have recovered from COVID-19 disease and those plasma units with a sufficiently high level of antibody will be used as a treatment. Public Health England (PHE) will be carrying out Testing on the Materials on behalf of NHSBT. This will involve: - A SARS-CoV-2 IgG antibody Testing service to NHSBT to enable the identification of convalescent plasma donations with sufficient level of antibody. - A SARS-CoV-2 PCR and RNA Testing service to NHSBT to support the Convalescent Plasma programme of work at NHSBT.

Ammendments to Previous Notice

Award Detail

CPV Codes

• 85111810 - Blood analysis services

Indicators

• Contract modified due to additional needs.

Legal Justification

The Rare and Imported Pathogens Laboratory (RIPL) based at PHE Porton (Sailsbury), providing the SARS-CoV-2 IgG antibody testing service, have experience in handling samples from NHSBT meeting all criteria specified in section 4.1 of the Project Schedule (dated 3rd March 2021). It is the only facility of its type within the UK that has the expertise to perform a quantitative test for SARS-CoV-2 IgG with a linear correlation with neutralising antibody over a very wide range of titres at the scale and speed required to meet the time pressures associated with the convalescent plasma programme.